Immuneering
IMRX
59 hedge funds and large institutions have $12.3M invested in Immuneering in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 11 increasing their positions, 18 reducing their positions, and 19 closing their positions.
47% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 19
16% more funds holding
Funds holding: 51 → 59 (+8)
8.19% less ownership
Funds ownership: 40.54% → 32.36% (-8.2%)
39% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 18
64% less capital invested
Capital invested by funds: $34.3M → $12.3M (-$22M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.46M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
+$904K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$631K |
| 4 |
Renaissance Technologies
New York
|
+$574K |
| 5 |
Goldman Sachs
New York
|
+$472K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$9.52M |
| 2 |
BlackRock
New York
|
-$1.39M |
| 3 |
HS
HighVista Strategies
Boston,
Massachusetts
|
-$736K |
| 4 |
State Street
Boston,
Massachusetts
|
-$506K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$396K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AWM
76
Avior Wealth Management
Omaha,
Nebraska
| – | -$11 | -4 | Closed |
|
77
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$44 | +27 | +1,350% |
|
|
CAL
78
Capital Advisors Ltd
Shaker Heights,
Ohio
| – | +$64 | +39 | New |
|
IMRX Hedge Fund Activity: Q2 2024 in Review
59 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Immuneering (IMRX) for Q2 2024, worth a combined $12.3M — down 64% from $34.3M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new IMRX positions and 19 closed out — a net gain of 9 holders — while 11 added to existing stakes and 18 trimmed.
The largest buyer was Millennium Management, adding an estimated $1.46M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $9.52M sold.
- 59 institutional investors held Immuneering (IMRX) as of Q2 2024, up from 51 in Q1 2024.
- Funds reported $12.3M of Immuneering stock for Q2 2024, down 64% quarter-over-quarter.
- 28 funds opened new Immuneering positions in Q2 2024 and 19 closed out, a net change of +9 holders.
- The largest Immuneering buyer in Q2 2024 was Millennium Management, an estimated $1.46M added.
- The largest Immuneering seller in Q2 2024 was Cormorant Asset Management, an estimated $9.52M sold.
Based on aggregated 13F filings for Q2 2024.